Use of a liquid nicotine delivery product to promote smoking cessation

Geimer, Nicholas; Olson, Carl E.; Baumgarten, Deborah; Kepner, James L.; Mahoney, Martin C.
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p155
Academic Journal
Background: Despite access to various pharmacotherapies and counseling support to aid cessation, smokers typically demonstrate quit rates below 50%. This report describes the results of a Phase 2a study exploring the efficacy of a liquid nicotine delivery system as an aid to smoking cessation assessed after 12 weeks of therapy. Methods: A single-arm Phase 2a study was conducted. Community-based smokers (ages 18+ years, smoking at least 10 cigarettes daily for the past year and interested in making a quit attempt) were recruited and completed clinic visits at 2 week intervals over the 12 week study period where carbon monoxide levels were assessed and the Smoke-Break product was rated on taste and overall satisfaction. Participants were provided with a supply of liquid nicotine cigarettes (e.g., Smoke-Break) at each clinic visit. A total of 69 smokers were enrolled and received the intervention product (intention to treat group, ITT) and 52 smokers verified participation (according to protocol group, ATP). Results: The cessation rate at 12 weeks after the baseline visit, assessed as the bioverified point prevalence of abstinence, was 71.1% (95% confidence interval [CI] 58.8%-83.5%) in the ATP group and 53.6% (41.8%-65.4%) in the ITT group. Participants rated the liquid nicotine delivery system highly and also expressed general satisfaction. Few adverse events were identified with no serious adverse events. Conclusions: These results support the efficacy of the liquid nicotine delivery system in smoking cessation. If this nicotine delivery product proves to be effective in larger trials, it could represent an inexpensive, readily accessible and well-tolerated agent to promote smoking cessation. Trial Registration: This trial is registered at clinicaltrials.gov as study NCT00715871.


Related Articles

  • Approaching tobacco dependence in youngsters: impact of an interactive smoking cessation program in a population of Romanian adolescents. Trofor, Antigona; Mihaicuta, Stefan; Man, Milena Adina; Miron, Ramona; Esanu, Valentina; Trofor, Letitia // Journal of Clinical & Experimental Investigations / Klinik ve De;2010, Vol. 1 Issue 3, p150 

    Objectives: The main objective of this study was to investigate the effectiveness of an interactive smoking cessation program when first implemented in a naïve population of Romanian adolescents. The secondary objective was to assess youngsters' attitudes and beliefs towards tobacco...

  • Carbon Monoxide Meter: The Essential Clinical Tool — the ‘Stethoscope’ — of Smoking Cessation. Bittoun, Renee // Journal of Smoking Cessation;Dec2008, Vol. 3 Issue 2, p69 

    The article focuses on the use of carbon monoxide monitor in the assessment of smoking status. The tool reportedly measures expired breath carbon monoxide in a noninvasive way. These expired breath carbon monoxide measurements have been used by clinicians and researchers to validate...

  • Clinicians Lack Smoking Cessation Training. Spellman, Marguerite // Pulmonary Reviews;Dec2008, Vol. 13 Issue 12, p1 

    The article presents the results of a health care providers survey in New York. The survey included questions regarding tobacco control issues, prevalence of smoking, tobacco treatment guidelines, cessation pharmacotherapy and interaction of nicotine with other drugs. It was found that many...

  • Pharmakologische Strategien zur Unterstützung einer Raucherentwöhnung. Vasic, N.; Wolf, R.C.; Wolf, N.; Connemann, B.J.; Sosic-Vasic, Z. // Der Nervenarzt;Nov2011, Vol. 82 Issue 11, p1449 

    Regular tobacco smoking occurs in about 35% of the male and 25% of the female German population. Individual attempts to independently quit smoking and to remain abstinent for 1 year have been shown to be successful in less than 5% of cases. This rate can be doubled by means of individual...

  • Pharmacotherapy for Smoking Cessation.  // CNS Drugs;2011, Vol. 25 Issue 5, p371 

    The article offers information on use of pharmacotherapy to help people quit smoking. It states that first-line agents to quit it are nicotine replacement therapy (NRT), varenicline and bupropion. It mentions that bupropion was used as anti-depressant in the U.S. and was later found to be...

  • Smoking cessation -- Tailoring your approach to the individual smoker. Attar-Zadeh, Danish // Practice Nurse;10/18/2013, Vol. 43 Issue 10, p18 

    The article discusses the approaches to stop cigarette smoking in Great Britain. It is reported that the prevalence of smoking in England is around 20%, and it causes more preventable deaths than anything else. Approximately 70% of smokers want to stop according to research conducted. Also...

  • Smoking Cessation Among Sheltered Homeless: A Pilot. Shelley, Donna; Cantrell, Jennifer; Wong, Selena; Warn, Doug // American Journal of Health Behavior;Sep/Oct2010, Vol. 34 Issue 5, p544 

    Objective: To test the feasibility and effect of a smoking cessation intervention among sheltered homeless. Methods: Homeless smokers were enrolled in a 12- week group counseling program plus pharmacotherapy (n=58). Results: The mean number of sessions attended was 7.2; most participants used at...

  • A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates. Rennard, Stephen; Hughes, John; Cinciripini, Paul M.; Kralikova, Eva; Raupach, Tobias; Arteaga, Carmen; St Aubin, Lisa B.; Russ, Cristina // Nicotine & Tobacco Research;Mar2012, Vol. 14 Issue 3, p343 

    Introduction: Current smoking cessation guidelines recommend setting a quit date prior to starting pharmacotherapy. However, providing flexibility in the date of quitting may be more acceptable to some smokers. The objective of this study was to compare varenicline 1 mg twice daily (b.i.d.) with...

  • Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems. Shahab, Lion; Brose, Leonie S.; West, Robert // CNS Drugs;Dec2013, Vol. 27 Issue 12, p1007 

    Nicotine replacement therapy (NRT) has been used in the treatment of tobacco dependence for over three decades. Whilst the choice of NRT was limited early on, in the last ten years there has been substantial increase in the number of nicotine delivery devices that have become available. This...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics